Clinical trial
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
NCT00078793 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00078793 |
|---|---|
| Title | Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis |
| Official title | Phase IV Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis |
| Lead sponsor | Amgen, Industry |
| Collaborators | Immunex Corporation Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Juvenile Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Enbrel® |
| Enrollment | 600 |
| Start date | Jun 1, 2000 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Mar 9, 2004 |
| Last update posted | May 14, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: